The Scientist

» ebola, evolution and microbiology

Most Recent

image: Evolutionary Rewiring

Evolutionary Rewiring

By | February 26, 2015

Strong selective pressure can lead to rapid and reproducible evolution in bacteria.

7 Comments

image: Rapid Ebola Test Approved

Rapid Ebola Test Approved

By | February 24, 2015

The World Health Organization OKs the first 15-minute Ebola diagnostic test.

0 Comments

image: Marine Life Trending Larger

Marine Life Trending Larger

By | February 23, 2015

Ocean animals have been getting bigger over the millennia, according to an analysis of thousands of genera that have plied Earth’s seas since the Cambrian Period.

0 Comments

image: Medical Equipment May Spread Superbug

Medical Equipment May Spread Superbug

By | February 20, 2015

Drug-resistant bacteria have spread in a Los Angeles hospital, perhaps from contaminated endoscopes.

1 Comment

image: Two New Jurassic Mammals Found

Two New Jurassic Mammals Found

By | February 13, 2015

Researchers working in China have unearthed the fossil remains of two diminutive mammals that speak volumes about faunal diversity during the Jurassic Period.

0 Comments

image: Ebola Victims Still Infectious a Week After Death

Ebola Victims Still Infectious a Week After Death

By | February 12, 2015

Ebola virus can remain infectious for up to seven days on the bodies of monkeys that died from the disease, researchers show.

0 Comments

image: Finch Findings

Finch Findings

By | February 12, 2015

Full genomes of Darwin’s Galápagos finches reveal a critical gene for beak shape and three overlooked species.

1 Comment

image: Trapped in Time

Trapped in Time

By | February 10, 2015

Ancient sulfur-eating deep-sea bacteria closely resemble modern variants, suggesting evolution may not occur in static environments.

1 Comment

image: Subway Microbiome

Subway Microbiome

By | February 9, 2015

Researchers document the bacterial life living among New York City’s transit stations.

0 Comments

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  4. Most of Human Genome Nonfunctional: Study
AAAS